Search Our Site

News tagged with:

"drug"

Experts Tell Congress How To Cut Drug Prices

The nation’s most influential science advisory group will tell Congress today that the U.S. pharmaceutical market is not sustainable and needs to change. “Drugs that are not affordable are of little value and drugs that do not exist are of no value,” said Norman Augustine, chair of the National Academies of Sciences, Engineering and Medicine’s... Read More »

Read More →

The nation’s most influential science advisory group will tell Congress today that the U.S. pharmaceutical market is not sustainable and needs to change. “Drugs that are not affordable are of little value and drugs that do not exist are of no value,” said Norman Augustine, chair of the National Academies of Sciences, Engineering and Medicine’s… Read More »

[...]

Read More

Pfizer Breast Cancer Drug Superior to Chemotherapy in Late Stage Study

(Reuters) – Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer Inc drug went about three months longer before their disease worsened than those who received chemotherapy in a late stage study, according to data released on Friday. The drug, talazoparib, a once daily pill that... Read More »

Read More →

(Reuters) – Patients with advanced breast cancer tied to an inherited gene mutation who were treated with an experimental Pfizer Inc drug went about three months longer before their disease worsened than those who received chemotherapy in a late stage study, according to data released on Friday. The drug, talazoparib, a once daily pill that… Read More »

[...]

Read More

California Governor Signs Law To Make Drug Pricing More Transparent

California Gov. Jerry Brown defied the drug industry Monday, signing the most comprehensive drug price transparency bill in the nation that will force drug makers to publicly justify big price hikes. “Californians have a right to know why their medical costs are out of control, especially when pharmaceutical profits are soaring,” Brown says. “This measure... Read More »

Read More →

California Gov. Jerry Brown defied the drug industry Monday, signing the most comprehensive drug price transparency bill in the nation that will force drug makers to publicly justify big price hikes. “Californians have a right to know why their medical costs are out of control, especially when pharmaceutical profits are soaring,” Brown says. “This measure… Read More »

[...]

Read More

How to cover Novartis’ $475K CAR-T drug Kymriah? A ‘new payment model’ is the only way, Express Scripts says

Steve Miller, the chief medical officer of Express Scripts, is one of the loudest voices in the ongoing debate over high drug prices, so it was only a matter of time before he weighed in on Kymriah, Novartis’ $475,000 CAR-T treatment for some patients with leukemia. That time came yesterday, and Miller didn’t mince words... Read More »

Read More →

Steve Miller, the chief medical officer of Express Scripts, is one of the loudest voices in the ongoing debate over high drug prices, so it was only a matter of time before he weighed in on Kymriah, Novartis’ $475,000 CAR-T treatment for some patients with leukemia. That time came yesterday, and Miller didn’t mince words… Read More »

[...]

Read More

Judge refuses to block Maryland price-gouging law

Opponents of a new law allowing Maryland to challenge generic drug price-gouging lost the first round of a legal battle Friday as a federal judge refused to block the measure. U.S. District Judge Marvin J. Garbis turned down a plea by a pharmaceutical industry group to issue an injunction against the law, which takes effect... Read More »

Read More →

Opponents of a new law allowing Maryland to challenge generic drug price-gouging lost the first round of a legal battle Friday as a federal judge refused to block the measure. U.S. District Judge Marvin J. Garbis turned down a plea by a pharmaceutical industry group to issue an injunction against the law, which takes effect… Read More »

[...]

Read More

When a Drug Coupon Helps You but Hurts Fellow Citizens

It’s completely rational for you to use coupons to lower the cost of your brand-name drug purchase. But if the coupon is causing you to switch away from a generic drug with an overall lower cost, you may be playing a role in pushing up drug spending and premiums for others. Let’s say that I... Read More »

Read More →

It’s completely rational for you to use coupons to lower the cost of your brand-name drug purchase. But if the coupon is causing you to switch away from a generic drug with an overall lower cost, you may be playing a role in pushing up drug spending and premiums for others. Let’s say that I… Read More »

[...]

Read More

Read the Fine Print on the $475,000 Price of a Cancer Breakthrough

Novartis could have priced Kymriah much higher, and it’s being unusually flexible. Kicking it off, Gilead Sciences Inc. bought Kite Pharma Inc., a pioneer in “CAR-T” cell therapy, which uses a patient’s immune cells to potentially eradicate blood cancers with just one treatment. And on Wednesday, Novartis AG’s entry in this field, Kymriah, became the first such... Read More »

Read More →

Novartis could have priced Kymriah much higher, and it’s being unusually flexible. Kicking it off, Gilead Sciences Inc. bought Kite Pharma Inc., a pioneer in “CAR-T” cell therapy, which uses a patient’s immune cells to potentially eradicate blood cancers with just one treatment. And on Wednesday, Novartis AG’s entry in this field, Kymriah, became the first such… Read More »

[...]

Read More

Lab-made “mini organs” helping doctors treat cystic fibrosis

UTRECHT, Netherlands — Els van der Heijden, who has cystic fibrosis, was finding it ever harder to breathe as her lungs filled with thick, sticky mucus. Despite taking more than a dozen pills and inhalers a day, the 53-year-old had to stop working and scale back doing the thing she loved best, horseback riding. Doctors... Read More »

Read More →

UTRECHT, Netherlands — Els van der Heijden, who has cystic fibrosis, was finding it ever harder to breathe as her lungs filled with thick, sticky mucus. Despite taking more than a dozen pills and inhalers a day, the 53-year-old had to stop working and scale back doing the thing she loved best, horseback riding. Doctors… Read More »

[...]

Read More

July/August 2017 Report: Doctors and Pharmacists underused for drug costs

The data come from the University of Michigan National Poll on Healthy Aging, a new initiative based at the U-M Institute for Healthcare Policy and Innovation and sponsored by AARP and Michigan Medicine, U-M’s academic medical center. “We already know that cost can keep patients from taking the drugs they need to maintain health or... Read More »

Read More →

The data come from the University of Michigan National Poll on Healthy Aging, a new initiative based at the U-M Institute for Healthcare Policy and Innovation and sponsored by AARP and Michigan Medicine, U-M’s academic medical center. “We already know that cost can keep patients from taking the drugs they need to maintain health or… Read More »

[...]

Read More

Novartis Drug Becomes First To Prevent Heart Attacks And Strokes By Targeting Inflammation

This morning, Novartis, the Swiss drug giant, announced that a drug that targets inflammation prevented heart attacks and strokes in a 10,000 patient trial of people with established heart disease. It could be a scientific breakthrough, and a commercial one, too. A lot will depend on full results that will be presented at a medical... Read More »

Read More →

This morning, Novartis, the Swiss drug giant, announced that a drug that targets inflammation prevented heart attacks and strokes in a 10,000 patient trial of people with established heart disease. It could be a scientific breakthrough, and a commercial one, too. A lot will depend on full results that will be presented at a medical… Read More »

[...]

Read More

Page 1 of 2

Categories
Archives